Chitosan solutions and particles: Evaluation of their permeation enhancing potential on MDCK cells used as blood brain barrier model
Authors:
- Andreas Bernkop-SchnürchABAndreas Bernkop-Schnürch
- 1 July 2009
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 376 (1-2) , 104-109
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Drug delivery and nanoparticles: Applications and hazardsInternational Journal of Nanomedicine, 2008
- In Vitro Assessment of Acyclovir Permeation Across Cell Monolayers in the Presence of Absorption EnhancersDrug Development and Industrial Pharmacy, 2008
- Modulation of Ganciclovir Intestinal Absorption in Presence of Absorption EnhancersJournal of Pharmaceutical Sciences, 2007
- Development and in vitro evaluation of a thiomer-based nanoparticulate gene delivery systemBiomaterials, 2007
- Nanoparticles in Drug Delivery and Environmental Exposure: Same Size, Same Risks?Nanomedicine, 2006
- In vitro models for the blood–brain barrierToxicology in Vitro, 2005
- Evaluation of the MDR-MDCK cell line as a permeability screen for the blood–brain barrierInternational Journal of Pharmaceutics, 2005
- Conversion of Zonulae Occludentes from Tight to Leaky Strand Type by Introducing Claudin-2 into Madin-Darby Canine Kidney I CellsJournal of Cell Biology, 2001
- Lactate dehydrogenase (LDH) activity of the number of dead cells in the medium of cultured eukaryotic cells as markerJournal of Biotechnology, 1992
- A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activityJournal of Immunological Methods, 1988